Exercise-induced stress inhibits both the induction and elicitation phases of in vivo T-cell-mediated immune responses in humans

Brain, Behavior, and Immunity

Volumn 25, Issue 6, 2011, Pages 1136-1142

  Harper Smith, Adam D ^a   Coakley, Sarah L ^a   Ward, Mark D ^a   Macfarlane, Andrew W ^b   Friedmann, Peter S ^c   Walsh, Neil P ^a  

^a BANGOR UNIVERSITY   (United Kingdom)

^b YSBYTY GWYNEDD   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Contact hypersensitivity; DPCP; Exercise; Immune; In vivo; Stress

Indexed keywords

DIPHENCYPRONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; EDEMA; ERYTHEMA; EXERCISE; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL MEMORY; IN VIVO STUDY; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REST; RUNNING; SEAT; SENSITIZATION; SKINFOLD THICKNESS; STRESS; T LYMPHOCYTE;

EID: 79960262490     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.02.014     Document Type: Article

References (32)

1. Albers R., Antoine J.M., Bourdet-Sicard R., Calder P.C., Gleeson M., Lesourd B., Samartin S., Sanderson I.R., Van Loo J., Vas Dias F.W., Watzl B. Markers to measure immunomodulation in human nutrition intervention studies. Br. J. Nutr. 2005, 94:452-481.
2. Araneo B.A., Dowell T., Moon H.B., Daynes R.A. Regulation of murine lymphokine production invivo - ultraviolet-radiation exposure depresses Il-2 and enhances Il-4 production by T-cells through an Il-1-dependent mechanism. J. Immunol. 1989, 143:1737-1744.
3. Bruce R.A. Methodology and interpretation of exercise tests. Cardiology 1977, 62:69-70.
4. Bruunsgaard H., Hartkopp A., Mohr T., Konradsen H., Heron I., Mordhorst C.H., Pedersen B.K. In vivo cell mediated immunity and vaccination response following prolonged, intense exercise. Med. Sci. Sports Exerc. 1997, 29:1176-1181.
5. Buckley D.A., Du Vivier A.W. The therapeutic use of topical contact sensitizers in benign dermatoses. Br. J. Dermatol. 2001, 145:385-405.
6. Cohen S., Miller G.E., Rabin B.S. Psychological stress and antibody response to immunization: a critical review of the human literature. Psychosom. Med. 2001, 63:7-18.
7. Cohen S., Tyrrell D.A.J., Smith A.P. Psychological stress and susceptibility to the common cold. N. Engl. J. Med. 1991, 325:606-612.
8. Cooper K.D., Oberhelman L., Hamilton T.A., Baadsgaard O., Terhune M., LeVee G., Anderson T., Koren H. UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc. Natl Acad. Sci. USA 1992, 89:8497-8501.
9. Dhabhar F.S. Stress-induced augmentation of immune function - The role of stress hormones, leukocyte trafficking, and cytokines. Brain Behav. Immun. 2002, 16:785-798.
10. Dhabhar F.S., McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl Acad. Sci. USA 1999, 96:1059-1064.
11. Dhabhar F.S., Viswanathan K. Short-term stress experienced at time of immunization induces a long-lasting increase in immunologic memory. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R738-R744.
12. Edwards K.M., Burns V.E., Reynolds T., Carroll D., Drayson M., Ring C. Acute stress exposure prior to influenza vaccination enhances antibody response in women. Brain Behav. Immun. 2006, 20:159-168.
13. Edwards K.M., Campbell J.P., Ring C., Drayson M.T., Bosch J.A., Downes C., Long J.E., Lumb J.A., Merry A., Paine N.J., Burns V.E. Exercise intensity does not influence the efficacy of eccentric exercise as a behavioural adjuvant to vaccination. Brain Behav. Immun. 2010, 24:623-630.
14. Friedmann P.S. Graded continuity, or all or none studies of the human immune-response. Clin. Exp. Dermatol. 1991, 16:80-84.
15. Friedmann P.S. Contact sensitisation and allergic contact dermatitis: immunobiological mechanisms. Toxicol. Lett. 2006, 162:49-54.
16. Friedmann P.S. The relationships between exposure dose and response in induction and elicitation of contact hypersensitivity in humans. Br. J. Dermatol. 2007, 157:1093-1102.
17. Friedmann P.S., Moss C., Shuster S., Simpson J.M. Quantitative relationships between sensitizing dose of dncb and reactivity in normal subjects. Clin. Exp. Immunol. 1983, 53:709-715.
18. Friedmann P.S., Pickard C. Quantifying human susceptibility to contact sensitisation; risk assessments now and in future. Contact Dermatitis 2010, 63:237-247.
19. Gleeson M. Immune function in sport and exercise. J. Appl. Physiol. 2007, 103:693-699.
20. Hopkins W.G. Measures of reliability in sports medicine and science. Sports Med. 2000, 30:1-15.
21. Kelly D.A., Walker S.L., McGregor J.M., Young A.R. A single exposure of solar simulated radiation suppresses contact hypersensitivity responses both locally and systemically in humans: quantitative studies with high-frequency ultrasound. J. Photochem. Photobiol. B: Biol. 1998, 44:130-142.
22. Levis W., Kaplan L. Topical diphenylcyclopropenone as a measure of immune competence in HIV seropositive subjects. J. Invest. Dermatol. 2005, 125:A37.
23. Memon A.A., Friedmann P.S. Studies on the reproducibility of allergic contact dermatitis. Br. J. Dermatol. 1996, 134:208-214.
24. Nieman D.C. Exercise, upper respiratory-tract infection, and the immune-system. Med. Sci. Sports Exerc. 1994, 26:128-139.
25. Palmer R.A., Friedmann P.S. Ultraviolet radiation causes less immunosuppression in patients with polymorphic light eruption than in controls. J. Invest. Dermatol. 2004, 122:291-294.
26. Peters E.M., Bateman E.D. Ultramarathon running and upper respiratory-tract infections - An epidemiological survey. S. Afr. Med. J. 1983, 64:582-584.
27. Rees J., Friedmann P.S., Matthews J.N.S. Contact sensitivity to dinitrochlorobenzene is impaired in atopic subjects - Controversy revisited. Arch. Dermatol. 1990, 126:1173-1175.
28. Sleijffers A., Garssen J., de Gruijl F.R., Boland G.J., van Hattum J., van Vloten W.A., van Loveren H. Influence of ultraviolet B exposure on immune responses following hepatitis B vaccination in human volunteers. J. Invest. Dermatol. 2001, 117:1144-1150.
29. Smith A., Vollmer-Conna U., Bennett B., Wakefield D., Hickie I., Lloyd A. The relationship between distress and the development of a primary immune response to a novel antigen. Brain Behav. Immun. 2004, 18:65-75.
30. Vukmanovic-Stejic M., Reed J.R., Lacy K.E., Rustin M.H.A., Akbar A.N. Mantoux test as a model for a secondary immune response in humans. Immunol. Lett. 2006, 107:93-101.
31. Walsh N.P., Gleeson M., Pyne D.B., Nieman D.C., Dhabhar F.S., Shephard R.J., Oliver S.J., Bermon S., Kajeniene A. Position statement part two: maintaining immune health. Exerc. Immunol. Rev. 2011, 17:64-103.
32. Walsh N.P., Gleeson M., Shephard R.J., Gleeson M., Woods J., Bishop N.C., Fleshner M., Green C., Pedersen B.K., Hoffman-Goetz L.H., Rogers C.J., Northoff H., Abbasi A., Simon P. Position statement part one: immune function and exercise. Exerc. Immunol. Rev. 2011, 17:6-63.